SNN News and Press, Smith & Nephew SNATS Inc. From 06/08/22

Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION PR Newswire LONDON , June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology busine...

Switzerland-based Healiva acquired two cell therapy assets from U.K.-based Smith & Nephew (NYSE:SNN) to bolster its portfolio of wounds care products. Financial details were not disclosed. Healiva said the the first asset, EpiDex is an autologous epidermal equivalent that provid...

Smith & Nephew has seen its business performance turn the corner post-pandemic and I expect future growth. The share price has crept up slightly but I continue to see long-term value here. I think there is upside for the patient investor, as well as dividend growth potential. ...

Zimmer Biomet has greatly underperformed the S&P 500 as well as the iShares IHI, been stagnant over the past 5 years. The street consensus gives some hope for the projected growth with an estimated 28.67% FCF and 7.19% EBIT CAGR over the next 5 years. Zimmer Biomet carries not...

Intuitive Surgical has massively outperformed the S&P 500 as well as the iShares IHI and is now in the middle of a severe price correction. Significant growth opportunity with projected 14.67% FCF and 18.35% EBIT CAGR over the next 5 years. Intuitive Surgical is by far the mar...

The management team at Insulet Corporation is due to report financial data for the first quarter of the company's 2022 fiscal year. Growth should come in strong, just as it has in prior years, and the long-term outlook for Insulet looks favorable. But PODD shares are far too price...

Smith & Nephew press release (NYSE:SNN): Q1 Revenue of $1.31B (+3.3% Y/Y) beats by $40M. Sports Medicine & ENT revenue up 8.6% underlying; Advanced Wound Management revenue up 8.0% underlying; Orthopaedics revenue up 2.6% underlying. Full year 2022 guidance remains unchanged. ...

Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors PR Newswire LONDON , March 31, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medic...

Smith+Nephew to showcase latest Orthopaedic advancements in Cementless Knees, Total Hip Arthroplasty and Robotics at AAOS 2022 Annual Meeting PR Newswire LONDON , March 22, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology bu...

Smith+Nephew to feature Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2022 Annual Meeting PR Newswire LONDON , March 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology bu...